|
Index of reports
> Cases with Pneumonia ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of Next >>
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Product Quality Issue, Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Lisinopril; Seroquel
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient:
Reactions: Weight Decreased, Pneumonia, Pruritus, Dyspnoea, Nausea, Pain, Haemoglobin Abnormal, Irritability, Diplopia, Fatigue, Lung Disorder, Dizziness, Asthenia, Decreased Appetite, Influenza
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Rebetol
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Telaprevir
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-02-07
Other drugs received by patient: Morphine; Synthroid; Oxycodone HCL; Nexium
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: Pneumonia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram
Start date: 2012-03-06
End date: 2012-03-13
PEG-Intron
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-05-15
PEG-Intron
Dosage: 0.75 microgram per kilogram, qw
Start date: 2012-03-20
End date: 2012-05-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-05-15
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-05-07
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Start date: 2012-05-15
End date: 2012-06-05
Telaprevir
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-06
End date: 2012-05-07
Other drugs received by patient: Betamethasone Sodium Phosphate; [therapy Unspecified]; Allegra; Allopurinol; Rabeprazole Sodium; Atarax; Meropenem
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-13
Patient:
Reactions: Pneumonia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-05-15
End date: 2012-07-03
Rebetol
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-15
End date: 2012-05-28
Rebetol
Administration route: Oral
Start date: 2012-05-29
End date: 2012-06-04
Rebetol
Administration route: Oral
Start date: 2012-06-05
End date: 2012-07-03
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-15
End date: 2012-07-03
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Victrelis
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient:
Reactions: Weight Decreased, Pneumonia, Nausea, Musculoskeletal Discomfort, Headache, Pyrexia, Eating Disorder, Dysgeusia, Diarrhoea, Skin Odour Abnormal, Heart Rate Increased, Chest Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-29
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-29
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-05-27
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Victrelis
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient:
Reactions: Pneumonia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1 df, qw
Indication: Hepatitis C
Rebetol
Victrelis
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-07-11
Patient:
Reactions: Abdominal Discomfort, Malaise, Pneumonia, Nasopharyngitis, Vomiting, Bronchitis, Cough
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Lisinopril; Seroquel
Possible PEG-Intron side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-27
Patient: male
Reactions: Haemorrhoid Operation, Pneumonia, Pain, Pulmonary Thrombosis, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-03-09
Ribavirin
Indication: Hepatitis C
Start date: 2012-03-09
Victrelis
Indication: Hepatitis C
Start date: 2012-04-13
Possible PEG-Intron side effects in 43 year old male
Reported by a physician from Portugal on 2012-06-19
Patient: 43 year old male
Reactions: Pneumonia, Anaemia, Drug Dependence, Septic Shock, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Heroin (Diamorphine)
Indication: Product Used FOR Unknown Indication
PEG-Intron
Indication: Product Used FOR Unknown Indication
Rebetol
Indication: Product Used FOR Unknown Indication
Victrelis
Indication: Product Used FOR Unknown Indication
Possible PEG-Intron side effects in 70 year old female
Reported by a physician from United States on 2012-06-12
Patient: 70 year old female
Reactions: Renal Failure, Pneumonia, Respiratory Failure, Anaemia, Bacterial Infection, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 mcg;qw;po
Administration route: Oral
Indication: Hepatitis C
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-03
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Hepatic Cirrhosis
Start date: 2011-11-03
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-08
Patient: female
Reactions: Weight Decreased, Pneumonia, Hepatitis C, Abasia, Fall, Tremor, Concussion, Disease Recurrence, Facial Bones Fracture
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2003-01-01
End date: 2003-07-01
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-14
Ribavirin
Indication: Hepatitis C
Start date: 2012-02-14
Ribavirin
Indication: Hepatitis C
Start date: 2003-01-01
End date: 2003-07-01
Possible PEG-Intron side effects in female
Reported by a physician from United States on 2012-04-27
Patient: female
Reactions: Pneumonia
Adverse event resulted in: death
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Ribavirin
Indication: Hepatitis C
Victrelis
Indication: Hepatitis C
Possible PEG-Intron side effects in 52 year old male
Reported by a consumer/non-health professional from Canada on 2012-04-20
Patient: 52 year old male
Reactions: Anxiety, Thrombosis, Dyspnoea, Pneumonia, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Heptovir
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Lung Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: qw
Indication: Hepatitis C
Start date: 2011-07-01
Ribavirin
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: qd, po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-02
Patient: 57 year old female
Reactions: Pneumonia, Staphylococcal Infection, Escherichia Infection, Candidiasis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Dosage: ;qw;
Indication: Hepatitis C
Start date: 2011-07-01
Ribavirin
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Victrelis
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-01
Victrelis
Dosage: ;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-01
End date: 2012-01-01
Possible PEG-Intron side effects in 64 year old male
Reported by a physician from Spain on 2012-03-23
Patient: 64 year old male, weighing 63.0 kg (138.6 pounds)
Reactions: Pneumonia, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Start date: 2012-01-13
Ribavirin
Dosage: 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-13
Victrelis
Dosage: 800 mg;q8h;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-10
Other drugs received by patient: Propranolol; Amiloride Hydrochloride
Possible PEG-Intron side effects in 52 year old male
Reported by a consumer/non-health professional from Canada on 2012-03-20
Patient: 52 year old male
Reactions: Thrombosis, Anxiety, Pneumonia, Headache, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in 57 year old female
Reported by a health professional (non-physician/pharmacist) from Australia on 2012-03-12
Patient: 57 year old female
Reactions: Pneumonia, Metabolic Acidosis, Necrosis, Hepatic Failure, Multi-Organ Failure, Renal Failure, Dialysis, Abscess, Pneumonia Staphylococcal, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Boceprevir (Sch-503034)
Dosage: 800 mg;tid
Indication: Hepatitis C
Start date: 2011-01-19
End date: 2012-01-30
PEG-Intron
Dosage: 100 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-01-19
End date: 2012-01-30
Ribavirin
Dosage: 400mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-01-19
End date: 2012-01-30
Possible PEG-Intron side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-28
Patient: 55 year old male
Reactions: Pneumonia, Vomiting, RED Blood Cell Count Decreased, Impaired Healing, Haemoptysis, Alopecia, Blood Count Abnormal, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-12-14
End date: 2012-02-03
PEG-Intron
Indication: Hepatitis C
Start date: 2009-12-30
End date: 2010-04-26
Procrit
Indication: Product Used FOR Unknown Indication
Rebetol
Indication: Hepatitis C
Start date: 2009-12-30
End date: 2010-04-26
Rebetol
Indication: Hepatitis C
Start date: 2011-12-15
End date: 2012-02-03
Victrelis
Indication: Hepatitis C
Start date: 2012-01-12
End date: 2012-02-03
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-21
Patient: female
Reactions: Pneumonia, Head Injury, Hypotension, Urinary Tract Infection, Abnormal Behaviour, Fall, Idiopathic Pulmonary Fibrosis, Mental Impairment, Insomnia, Feeling Abnormal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-08-26
End date: 2011-12-24
Ribavirin
Indication: Hepatitis C
Start date: 2011-08-26
End date: 2011-12-24
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-15
Patient: female
Reactions: White Blood Cell Count Decreased, Pneumonia, Chest Discomfort, Pulmonary Sarcoidosis, Incorrect Dose Administered, Biopsy Larynx Abnormal, Pyrexia, Staphylococcal Infection, Mental Disorder, Memory Impairment
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-01-09
PEG-Intron
Indication: Hepatitis C
Start date: 2011-01-07
End date: 2011-08-15
Ribavirin
Indication: Hepatitis C
Start date: 2012-01-09
Ribavirin
Indication: Hepatitis C
Start date: 2011-01-07
End date: 2011-08-15
Telaprevir
Indication: Hepatitis C
Start date: 2012-01-09
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-13
Patient:
Reactions: Hepatic Encephalopathy, Pneumonia, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Victrelis
Indication: Hepatitis C
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-09
Patient:
Reactions: Pneumonia, Hepatic Encephalopathy, Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Victrelis
Indication: Hepatitis C
Possible PEG-Intron side effects in 26 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01
Patient: 26 year old male, weighing 69.9 kg (153.7 pounds)
Reactions: Pneumonia, Respiratory Failure, Respiratory Arrest, Infection
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
PEG-Intron
Other drugs received by patient: Humira; Fosamax; Atenolol; Adderall 5; Entocort EC; Luvox
Possible PEG-Intron side effects in 61 year old male
Reported by a physician from Hungary on 2012-01-31
Patient: 61 year old male
Reactions: Haemoglobin Decreased, Agranulocytosis, Pneumonia, Thrombocytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 150 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-09-30
Rebetol
Dosage: 1200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-30
Victrelis
Dosage: 2400 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-30
Possible PEG-Intron side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-26
Patient: female
Reactions: Pneumonia, Staphylococcal Infection, Sarcoidosis, Pharyngitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2011-01-07
End date: 2011-08-15
Ribavirin
Indication: Hepatitis C
Start date: 2011-01-07
End date: 2011-08-15
Possible PEG-Intron side effects in 26 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-13
Patient: 26 year old male
Reactions: Pneumonia, Respiratory Failure
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Fosamax
Administration route: Oral
End date: 2011-10-06
PEG-Intron
Indication: Hepatitis C
Start date: 2011-07-22
End date: 2011-10-06
Other drugs received by patient: Atenolol; Luvox; Entocort EC; Humira; Adderall Tablets; Vitamins (Unspecified)
Possible PEG-Intron side effects in 44 year old male
Reported by a physician from Germany on 2011-12-05
Patient: 44 year old male, weighing 80.0 kg (176.0 pounds)
Reactions: Agitation, Hemiparesis, Loss of Consciousness, Polyneuropathy, Hyperventilation, Haemangioma of Liver, Dialysis, Decubitus Ulcer, Depression, Thrombocytopenia, Renal Failure Acute, Refusal of Treatment by Patient, Pneumonia, Cellulitis, Hypothermia, Hyponatraemia, Perichondritis, Hypophosphataemia, Respiratory Failure, Oedematous Pancreatitis, Withdrawal Syndrome, Normochromic Normocytic Anaemia, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2011-03-22
End date: 2011-08-21
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-03-22
Page 1 Next >>
|
